Based in Paris (France), ÓSKARE CAPITAL is advising Dublin based Oskare Fund I, an AIFM and ESG compatible Óskare Fund I launched in Q2, 2020. This pioneer investment fund (up to €150 M) will be investing principally in European companies and teams that are working with cannabinoids and the related infrastructure, and which are developing disruptive solutions and emerging technologies within this medical and healthcare sector.